Teleflex Incorporated $TFX Holdings Decreased by State of Alaska Department of Revenue

State of Alaska Department of Revenue trimmed its position in Teleflex Incorporated (NYSE:TFX) by 58.5% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 7,148 shares of the medical technology company’s stock after selling 10,066 shares during the quarter. State of Alaska Department of Revenue’s holdings in Teleflex were worth $893,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Diamond Hill Capital Management LLC Investment Advisor bought a new stake in shares of Teleflex in the second quarter valued at about $39,467,000. Assenagon Asset Management S.A. purchased a new stake in Teleflex in the second quarter worth about $1,391,000. Fifth Third Bancorp lifted its stake in Teleflex by 3,204.8% in the first quarter. Fifth Third Bancorp now owns 68,144 shares of the medical technology company’s stock worth $8,151,000 after acquiring an additional 66,082 shares during the period. Irenic Capital Management LP purchased a new stake in Teleflex in the first quarter worth about $104,061,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Teleflex during the 2nd quarter worth about $1,065,000. Institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of TFX stock opened at $130.47 on Thursday. Teleflex Incorporated has a fifty-two week low of $100.18 and a fifty-two week high of $145.00. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60. The firm has a market capitalization of $5.53 billion, a price-to-earnings ratio of -5.60, a PEG ratio of 0.88 and a beta of 0.83. The stock’s 50-day simple moving average is $130.95 and its 200-day simple moving average is $130.62.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.28 by $0.48. The firm had revenue of $570.33 million during the quarter, compared to analyst estimates of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. Teleflex’s revenue was up 28.9% on a year-over-year basis. During the same period last year, the firm posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, equities analysts forecast that Teleflex Incorporated will post 7.22 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th were paid a dividend of $0.34 per share. The ex-dividend date was Friday, August 14th. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s dividend payout ratio is presently -5.84%.

Wall Street Analyst Weigh In

A number of research firms have commented on TFX. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research report on Monday, September 21st. Truist Financial reduced their price target on shares of Teleflex from $150.00 to $142.00 and set a “hold” rating for the company in a report on Wednesday, October 14th. Wall Street Zen raised shares of Teleflex from a “sell” rating to a “hold” rating in a research report on Sunday, August 9th. BMO Capital Markets initiated coverage on shares of Teleflex in a research note on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price objective on the stock. Finally, Zacks Research upgraded shares of Teleflex from a “hold” rating to a “strong-buy” rating in a research note on Thursday, September 24th. Two analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $154.40.

Teleflex Profile

Teleflex Incorporated is a global medical technology company that develops, manufactures and markets specialty medical devices. Its products are designed to support healthcare professionals in critical care and procedural settings, including vascular access, interventional cardiology and radiology, anesthesia, respiratory care, emergency medicine, surgical applications and urology.

The company’s portfolio includes catheters, access and closure devices, airway-management products, surgical instruments, pain-management devices and other technologies used in hospitals and outpatient facilities.